Outpatient treatment of community- acquired pneumonia: Evolving trends and a focus on fluoroquinolones

Canadian Journal of Clinical Pharmacology

Volumn 13, Issue 1, 2006, Pages

  Carrie, Anita G ^a,b   Kozyrskyj, Anita L ^c,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antibiotics; Community acquired pneumonia; Drug utilization; Fluoroquinolones; Outpatients

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFIXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRACTICE GUIDELINE; SOCIOECONOMICS; URBAN AREA; ADOLESCENT; AMBULATORY CARE; CANADA; COMMUNICABLE DISEASE; INCOME; MIDDLE AGED; PNEUMONIA; RURAL POPULATION; STATISTICS; URBAN POPULATION;

ADOLESCENT; ADULT; AMBULATORY CARE; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; FEMALE; FLUOROQUINOLONES; HUMANS; INCOME; MALE; MANITOBA; MIDDLE AGED; PNEUMONIA; RURAL POPULATION; URBAN POPULATION;

EID: 33645803584     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-219.
2. Carrie AG, Metge CJ, Zhanel GG. Antibiotic use in a Canadian Province, 1995-1998. Ann Pharmacother 2000;34:459-64.
3. Kozyrskyj AL, Carrie AG, Mazowita GB, Lix LM, Klassen TP, Law BJ. Decrease in antibiotic use in children in the 1990's: not all antibiotics, not all children. Can Med Assoc J 2004.
4. McManus P, Hammond ML, Whicker SD, Primrose JG, Mant A, Fairall SR. Antibiotic use in the Australian community, 1990-1995. Med J Aust 1997;167:124-127.
5. Henricson K, Melander E, Molstad S et al. Intra-urban variation of antibiotic utilization in children: influence of socio-economic factors. Eur J Clin Pharmacol 1998;54:653-657.
6. McCombs JS, Nichol MB. The use of first and second-line outpatient antibiotics under the Saskatchewan Drug Plan. Pharmacoeconomics 1995;7:543-554.
7. Straand J, Rokstad K, Sandvik H. Prescribing systemic antibiotics in general practice. A report from the More and Romsdal Prescription Study. Scand J Prim Health Care 1997;16:121-127.
8. LeLorier J, Derderian F. Effect of listing ciprofloxacin in provincial formularies on hospitalizations for bronchitis and pyelonephritis. Can J Clin Pharmacol 1998;5:133-137.
9. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31:383-421.
10. Mandell LA, Niederman M. Antimicrobial treatment of community acquired pneumonia in adults: A conference report. Can J Infect Dis 1993;4:25-28.
11. Manitoba Health. Manitoba drug benefits and interchangeability formulary. http://www.gov.mb.ca/health/mdbif/pdca48.pdf (November 13, 2005).
12. Reid R, MacWilliams L, Roos NP, Bogdanovic B, Black C. Measuring morbidity in populations: performance of the John Hopkins Adjusted Clinical Group (ACG) Case-Mix System in Manitoba. Winnipeg: Manitoba Centre for Health Policy; 1999.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
14. Birkett DJ, Mitchell AS, Godeck A, Grigson T, Cully R, Lee C. Profiles of antibacterial drug use in Australia and trends from 1987 to 1989. Med J Aust 1991;155:410-415.
15. Steinman MA, Gonzales R, Linder JA, Landefeld S. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003;138:525-533.
16. Malcolm C, Marrie TJ. Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Arch Intern Med 2003;163:797-802.
17. Pennie RA. Prospective study of antibiotic prescribing for children. Can Fam Physician 1998;44:1850-1856.
18. Raisch DW. A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model. Ann Pharmacother 1990;24:537-542.
19. Bateman DN, Campbell M, Donaldson LJ, Roberts SJ, Smith JM. A prescribing incentive scheme for non-fundholding general practices: an observational study. Br Med J 1996;313:535-538.
20. Himmelberg CJ, Pleasants RA, Weber DJ et al. Use of antimicrobial drugs in adults before and after removal of a restriction policy. Am J Hosp Pharm 1991;48:1220-1227.
21. Sketris IS, Metge C, Shevchuk Y et al. Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: relationship to drug insurance reimbursement policies. Am J Geriatric Pharmacotherapy 2004;2:24-35.
22. Cates C. An evidenced based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. Br Med J 1999;318:715-6.
23. Ilett KF, Johnson S, Greenhill G et al. Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer). Br J Clin Pharmacol 2000;49:168-173.
24. Stewart J, Pilla J, Dunn L. Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics. Can Fam Physician 2000;46:851-9.
25. Majumdar SR, Soumerai SB. Why most interventions to improve physician prescribing do not seem to work. CMAJ 2003;169:30-1.
26. Humphries KH, Rankin JM, Carere RG, Buller CE, Kiely FM, Spinelli JJ. Comorbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol 2000;53:343-9.